0 Ratings

ID

17396

Description

Pemetrexed +/- Carboplatin as Second Line Treatment in NSCLC; ODM derived from: https://clinicaltrials.gov/show/NCT00786331

Link

https://clinicaltrials.gov/show/NCT00786331

Keywords

  1. 9/11/16 9/11/16 -
Uploaded on

September 11, 2016

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :


    No comments

    In order to download data models you must be logged in. Please log in or register for free.

    Eligibility Advanced Non-Small Cell Lung Cancer NCT00786331

    Eligibility Advanced Non-Small Cell Lung Cancer NCT00786331

    Inclusion Criteria
    Description

    Inclusion Criteria

    Alias
    UMLS CUI
    C1512693
    written informed consent
    Description

    written informed consent

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0021430
    histologically or cytologically confirmed non-small-cell lung cancer
    Description

    non-small-cell lung cancer

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0007131
    unresectable stage iiib, stage iv and unresectable local relapse or metastatic disease, with evidence of disease progression after first line chemotherapy which should have included a platinum agent.
    Description

    metastatic disease

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0027627
    ecog performance status lower than or equal to 2
    Description

    ecog

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C1520224
    adequate hematological, hepatic and renal functions
    Description

    hepatic and renal functions

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0232805
    UMLS CUI [2]
    C0232741
    life expectancy greater than or equal to 12 weeks
    Description

    life expectancy

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0023671
    prior treatment with only 1 chemotherapy regimen for the treatment of advanced disease which should have included a platinum agent
    Description

    chemotherapy regimen

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0392920
    at baseline, presence of at least one measurable target lesion as per recist criteria
    Description

    measurable target lesion

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C1513041
    Exclusion Criteria
    Description

    Exclusion Criteria

    Alias
    UMLS CUI
    C0680251
    prior treatment with pemetrexed.
    Description

    pemetrexed

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0210657
    patients who are pregnant or lactating
    Description

    pregnant or lactating

    Data type

    boolean

    Alias
    UMLS CUI [1,1]
    C0032961
    UMLS CUI [1,2]
    C0006147
    patients with any underlying medical condition that might be aggravated by treatment or which cannot be controlled.
    Description

    medical condition

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0012634
    symptomatic brain metastases
    Description

    brain metastases

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0220650
    history of another malignancy within the past five years except basal cell carcinoma of the skin or carcinoma in situ of the cervix.
    Description

    malignancy

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C0006826
    concomitant treatment with any other anticancer drug.
    Description

    concomitant treatment

    Data type

    boolean

    Alias
    UMLS CUI [1]
    C1707479

    Similar models

    Eligibility Advanced Non-Small Cell Lung Cancer NCT00786331

    Name
    Type
    Description | Question | Decode (Coded Value)
    Data type
    Alias
    Item Group
    C1512693 (UMLS CUI)
    written informed consent
    Item
    written informed consent
    boolean
    C0021430 (UMLS CUI [1])
    non-small-cell lung cancer
    Item
    histologically or cytologically confirmed non-small-cell lung cancer
    boolean
    C0007131 (UMLS CUI [1])
    metastatic disease
    Item
    unresectable stage iiib, stage iv and unresectable local relapse or metastatic disease, with evidence of disease progression after first line chemotherapy which should have included a platinum agent.
    boolean
    C0027627 (UMLS CUI [1])
    ecog
    Item
    ecog performance status lower than or equal to 2
    boolean
    C1520224 (UMLS CUI [1])
    hepatic and renal functions
    Item
    adequate hematological, hepatic and renal functions
    boolean
    C0232805 (UMLS CUI [1])
    C0232741 (UMLS CUI [2])
    life expectancy
    Item
    life expectancy greater than or equal to 12 weeks
    boolean
    C0023671 (UMLS CUI [1])
    chemotherapy regimen
    Item
    prior treatment with only 1 chemotherapy regimen for the treatment of advanced disease which should have included a platinum agent
    boolean
    C0392920 (UMLS CUI [1])
    measurable target lesion
    Item
    at baseline, presence of at least one measurable target lesion as per recist criteria
    boolean
    C1513041 (UMLS CUI [1])
    Item Group
    C0680251 (UMLS CUI)
    pemetrexed
    Item
    prior treatment with pemetrexed.
    boolean
    C0210657 (UMLS CUI [1])
    pregnant or lactating
    Item
    patients who are pregnant or lactating
    boolean
    C0032961 (UMLS CUI [1,1])
    C0006147 (UMLS CUI [1,2])
    medical condition
    Item
    patients with any underlying medical condition that might be aggravated by treatment or which cannot be controlled.
    boolean
    C0012634 (UMLS CUI [1])
    brain metastases
    Item
    symptomatic brain metastases
    boolean
    C0220650 (UMLS CUI [1])
    malignancy
    Item
    history of another malignancy within the past five years except basal cell carcinoma of the skin or carcinoma in situ of the cervix.
    boolean
    C0006826 (UMLS CUI [1])
    concomitant treatment
    Item
    concomitant treatment with any other anticancer drug.
    boolean
    C1707479 (UMLS CUI [1])

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial